Brief: Myriad Genetics Identifies Disparities Between Genesight & Non-Genesight Control Group In Baseline Hospital Resource Utilization & Costs In Analysis

Myriad Genetics

04/09/2024 11:17

Sept 4 (Reuters) - Myriad Genetics Inc  MYGN.O :
    * MYRIAD GENETICS: IDENTIFIED DISPARITIES BETWEEN GENESIGHT
&
NON-GENESIGHT CONTROL GROUP IN BASELINE HOSPITAL RESOURCE
UTILIZATION & COSTS IN ANALYSIS
    * MYRIAD GENETICS: DISPARITIES INDICATED NON-GENESIGHT
CONTROL
GROUP WAS NOT VIABLE CONTROL FOR PART TWO OF STUDY OF GENESIGHT
TESTING - SEC FILING
    * MYRIAD GENETICS INC: CONCLUDED THAT ANY DATA COMPARING
GENESIGHT
PATIENT GROUP AGAINST NON-GENESIGHT CONTROL GROUP WERE NOT
RELIABLE
    * MYRIAD GENETICS INC: HAS DETERMINED TO DISCONTINUE
ANALYSIS FOR
PART TWO OF STUDY

Source text for Eikon:  ID:n0000899923-24-000045 
Further company coverage:  MYGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))